Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2005 1
2007 2
2008 1
2009 2
2010 3
2011 5
2012 1
2013 3
2014 3
2015 2
2016 3
2017 4
2018 3
2019 1
2020 7
2021 2
2022 6
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Nimotuzumab: beyond the EGFR signaling cascade inhibition.
Mazorra Z, Chao L, Lavastida A, Sanchez B, Ramos M, Iznaga N, Crombet T. Mazorra Z, et al. Among authors: crombet t. Semin Oncol. 2018 Jan;45(1-2):18-26. doi: 10.1053/j.seminoncol.2018.04.008. Epub 2018 May 2. Semin Oncol. 2018. PMID: 30318080 Free article. Review.
CIMAvax-EGF: Toward long-term survival of advanced NSCLC.
Saavedra D, Neninger E, Rodriguez C, Viada C, Mazorra Z, Lage A, Crombet T. Saavedra D, et al. Among authors: crombet t. Semin Oncol. 2018 Jan;45(1-2):34-40. doi: 10.1053/j.seminoncol.2018.04.009. Epub 2018 May 1. Semin Oncol. 2018. PMID: 30318082 Free article. Review.
COVID-19 and Cancer in Cuba.
Rubio MC, Sanchez L, Abreu-Ruíz G, Bermejo-Bencomo W, Crombet T, Lage A. Rubio MC, et al. Among authors: crombet t. Semin Oncol. 2020 Oct;47(5):328-329. doi: 10.1053/j.seminoncol.2020.07.009. Epub 2020 Aug 7. Semin Oncol. 2020. PMID: 32994047 Free PMC article.
NeuroEPO plus (NeuralCIM®) in mild-to-moderate Alzheimer's clinical syndrome: the ATHENEA randomized clinical trial.
Sosa S, Bringas G, Urrutia N, Peñalver AI, López D, González E, Fernández A, Hernández ZM, Viña A, Peña Y, Batista JF, Valenzuela C, León K, Crombet T, Rodríguez T, Pérez L; ATHENEA Investigators. Sosa S, et al. Among authors: crombet t. Alzheimers Res Ther. 2023 Dec 13;15(1):215. doi: 10.1186/s13195-023-01356-w. Alzheimers Res Ther. 2023. PMID: 38093366 Free PMC article. Clinical Trial.
Control of advanced cancer: the road to chronicity.
Lage A, Crombet T. Lage A, et al. Among authors: crombet t. Int J Environ Res Public Health. 2011 Mar;8(3):683-97. doi: 10.3390/ijerph8030683. Epub 2011 Mar 1. Int J Environ Res Public Health. 2011. PMID: 21556173 Free PMC article. Review.
Immune, inflammatory and prothrombotic parameters in COVID-19 patients treated with an anti EGFR antibody.
Saavedra D, Añé-Kourí AL, Gregorich EML, Mena J, Lorenzo-Luaces P, Londres HD, Martínez AH, Armada JJ, Sánchez YH, González YZ, Troche M, Medel L, Ramos M, Crombet T. Saavedra D, et al. Among authors: crombet t. Immunol Lett. 2022 Dec;251-252:1-8. doi: 10.1016/j.imlet.2022.09.005. Epub 2022 Sep 27. Immunol Lett. 2022. PMID: 36174772 Free PMC article.
Nimotuzumab Increases the Recovery Rate of Severe and Critical COVID-19 Patients: Evaluation in the Real-World Scenario.
Diaz H, Jiménez J, Hernández A, Valdés L, Martínez A, Porto L, Hernández R, Travieso N, Jova JH, Medel L, Troche M, Gorte A, Batista D, Valls AR, Cabrera L, Domeq M, Pérez L, Lorenzo-Luaces P, Sánchez L, Saavedra D, Ramos M, Crombet T. Diaz H, et al. Among authors: crombet t. Front Public Health. 2022 Jul 22;10:948520. doi: 10.3389/fpubh.2022.948520. eCollection 2022. Front Public Health. 2022. PMID: 35937253 Free PMC article.
52 results